Is this your company? Get featured or correct your listing →
Recent changes
- Jun 10, 2026Jun 10, 2026SonoThera Raises $125M for Ultrasound Gene Therapy Pulse story
- Jun 8, 2026Jun 8, 2026Raised $125.5M SEC EDGAR Form D
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Jun 8, 2026 | funding round | $125.5M | — | SEC EDGAR Form D |
Investors
Latest Pulse
- Jun 10, 2026SonoThera Raises $125M for Ultrasound Gene TherapySonoThera closed an oversubscribed $125 million Series B led by Vida Ventures to push its ultrasound-delivered, nonviral genetic medicine platform toward its first clinical trial in Duchenne muscular dystrophy in 2027.→
- Jun 8, 2026HCW Biologics Files S-1 for Small $5.6M Best-Efforts RaiseHCW Biologics filed an S-1 for a best-efforts offering of up to $5.6 million, a modest raise reflecting the tighter capital-access conditions many small-cap clinical-stage biotechs still face despite the broader 2026 IPO boom.→
Coverage Timeline
newest firstAll Coverage
Related Companies
SonoThera FAQ
Who are SonoThera's investors?
SonoThera's investors include ARCH Venture Partners.
Sources & methodologyshow
Where these figures come from
- SEC EDGAR Form Dprimary source1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.